Enhancement of antibody responses by IgD-binding factors induced by anti-IgD treatment of spleen cells.

Keyphrases

• Antibody Response 100%
• Binding Factors 100%
• Spleen Cells 100%
• Splenocytes 50%
• B Cells 50%
• Delta Receptor 50%
• T Cells 25%
• Lymphocytes 25%
• Molecular Mass 25%
• Incubation 25%
• IgG1 25%
• Cell Response 25%
• Cellular Mechanisms 25%
• Erythrocytes 25%
• Gel Filtration 25%
• IgM Antibody 25%
• Soluble Factors 25%
• Polymerized 25%
• Sheep Erythrocytes 25%
• Anti-IgM 25%
• Mouse Spleen Cell 25%
• Rosette Formation 25%
• Plaque Forming Cells 25%

Immunology and Microbiology

• Antibody Response 100%
• Splenocyte 100%
• Immunoglobulin D 100%
• Surface Property 20%
• Mouse 20%
• Lymphocyte 20%
• B Cell 20%
• T Cell 10%
• Immunoglobulin G1 10%
• Molecular Weight 10%
• Rosette Formation 10%
• Immunoglobulin M 10%
• Erythrocyte 10%
• Immunoglobulin M Antibody 10%
• Sheep Erythrocyte 10%
• Gel Filtration 10%
• Immunoglobulin D Antibody 10%
• Plaque Forming Cell 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Immunoglobulin D Antibody 10%